155 related articles for article (PubMed ID: 8150100)
21. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
Falsetti L; Gambera A
Fertil Steril; 1999 Jul; 72(1):41-6. PubMed ID: 10428146
[TBL] [Abstract][Full Text] [Related]
22. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.
Dikensoy E; Balat O; Pence S; Akcali C; Cicek H
Arch Gynecol Obstet; 2009 Mar; 279(3):321-7. PubMed ID: 18607612
[TBL] [Abstract][Full Text] [Related]
23. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism.
Erenus M; Yücelten D; Durmuşoğlu F; Gürbüz O
Fertil Steril; 1997 Dec; 68(6):1000-3. PubMed ID: 9418687
[TBL] [Abstract][Full Text] [Related]
24. Comparison of finasteride versus flutamide in the treatment of hirsutism.
Falsetti L; Gambera A; Legrenzi L; Iacobello C; Bugari G
Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.
Müderris II; Bayram F; Sahin Y; Keleştimur F; Tutuş A; Ayata D
Fertil Steril; 1996 Aug; 66(2):220-2. PubMed ID: 8690105
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Sert M; Tetiker T; Kirim S
Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
[TBL] [Abstract][Full Text] [Related]
27. New alternative treatment in hirsutism: bicalutamide 25 mg/day.
Müderris II; Bayram F; Ozçelik B; Güven M
Gynecol Endocrinol; 2002 Feb; 16(1):63-6. PubMed ID: 11915584
[TBL] [Abstract][Full Text] [Related]
28. Predictors of clinical response in hirsute women treated with spironolactone.
Crosby PD; Rittmaster RS
Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
[TBL] [Abstract][Full Text] [Related]
29. Androgen-receptor blockade does not impair bone mineral density in adolescent females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Costa S; Battini R; Saggese G
Calcif Tissue Int; 1997 Jul; 61(1):1-5. PubMed ID: 9192502
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism.
Prezelj J; Kocijancic A; Andolsek L
Gynecol Endocrinol; 1989 Dec; 3(4):281-8. PubMed ID: 2516705
[TBL] [Abstract][Full Text] [Related]
31. Compromise in the treatment of hirsutism with flutamide.
Tremblay RR
In Vivo; 1993; 7(6A):549-51. PubMed ID: 8193275
[TBL] [Abstract][Full Text] [Related]
32. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
[TBL] [Abstract][Full Text] [Related]
33. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Lumachi F; Rondinone R
Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
[TBL] [Abstract][Full Text] [Related]
34. Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.
Moghetti P; Castello R; Zamberlan N; Rossini M; Gatti D; Negri C; Tosi F; Muggeo M; Adami S
J Clin Endocrinol Metab; 1999 Apr; 84(4):1250-4. PubMed ID: 10199763
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
[TBL] [Abstract][Full Text] [Related]
36. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
[TBL] [Abstract][Full Text] [Related]
37. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
[TBL] [Abstract][Full Text] [Related]
40. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism.
Müderris II; Bayram F; Sahin Y; Keleştimur F
Fertil Steril; 1997 Oct; 68(4):644-7. PubMed ID: 9341603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
